Phase 1 Study of ONO-7269 Intravenous Infusion in Healthy Japanese Subjects
Latest Information Update: 10 Jan 2022
At a glance
- Drugs ONO 7269 (Primary)
- Indications Cerebral infarction
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors Ono Pharmaceutical
- 07 Dec 2021 Status changed from not yet recruiting to completed.
- 12 Nov 2018 New trial record